Portfolio Lab

Dolby Laboratories, Inc.

  • Stock
  • Ticker DLB
  • ISIN US25659T1079
  • NYSE

Industrials · Business services · USA

$55.33 +1.02%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Dolby Laboratories, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

DLBGlobal equities (VT)

$10,000 grew to $13,473. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −49.2% in 07/2026, measured from the peak in 05/2021. The old peak has not been reached again yet.

1-year return
−13.6%
5-year return p.a.
−7.7%
10-year return p.a.
+3.0%
Volatility p.a.
22.6%
Largest decline
−49.2%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue357370316307347396305374
Gross profit316334272268303351265315
Operating income801084830621133495
EBITDA10212970528613757119
Net income6892464953952981
Earnings per share0.700.940.480.510.550.990.300.86
Balance sheet
Total assets3,1593,2293,1963,2283,1923,2493,1573,169
Liabilities642646582596589622564556
Equity2,5082,5742,6052,6232,5942,6182,5842,604
Cash521627699702644594669623
Cash flow
Operating cash flow10717568123559316785
Capital expenditure-6.8-6.9-6.4-16-4.6-9.1-15-11
Free cash flow10016861107508315274

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2020 at +43.0%, weakest 2022 at −24.9%. 5 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
17 Nov 2026$0.86
30 Jul 2026$0.30
30 Apr 2026$0.99
29 Jan 2026$0.55
18 Nov 2025$0.51
31 Jul 2025$0.48
1 May 2025$0.94
30 Jan 2025$0.70
19 Nov 2024$0.60
7 Aug 2024$0.40
2 May 2024$1.01
2 Feb 2024$0.69

Key metrics

Metrics of 18 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€4.8bn
Market cap in trading currency
$5.29bn
Enterprise value
$4.67bn
P/E
20.5
P/S
3.72
P/B
2.03
EV/Sales
3.28
EV/EBITDA
11.7
Earnings yield
4.9%
FCF yield
6.8%

Results (last four quarters)

Revenue
$1.42bn
Gross profit
$1.23bn
EBITDA
$399m
Net income
$258m
Earnings per share
$2.70
Revenue per share
$14.86
Revenue growth
+21.7%
Earnings growth
+64.0%

Profitability

Gross margin
86.9%
Operating margin
21.4%
Net margin
18.1%
Return on equity
9.9%
Return on assets
8.1%

Balance sheet and cash flow

Cash
$623m
Cash per share
$6.52
Financial debt
–
Debt/equity %
–
Current ratio
3.18
Book value per share
$27.24
Operating cash flow
$400m
Free cash flow
$360m

Dividend

Dividend yield
2.60%
Dividend (12 months)
$1.44
Yield (12 months)
2.60%
Payout ratio
53%
Ex-dividend date
11 Aug 2026

Shares and trading

Shares outstanding
95.6m
Volume
1.35m
Avg. volume 3 months
892,730
Relative volume
1.4

Price and technicals

Price
$55.33
1 day
+1.0%
52-week high
$69.09
52-week low
$48.51
Distance to 52-week high
−19.9%
Distance to 52-week low
+14.1%
Distance to 50-day line
−8.5%
Distance to 200-day line
−6.6%
RSI (14)
27
Volatility 1M
30.2%

Performance

1 week
−13.0%
1 month
−12.6%
3 months
−16.2%
6 months
+1.1%
YTD
−13.8%
1 year
−14.9%

Dates

Fiscal year end
25 Sep 2026
Most recent quarter
25 Sep 2026

Frequently asked questions

How has DLB performed since 11/2016?

$10,000 grew to $13,473 by 20 Nov 2026, which is +3.0% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is DLB?

Volatility was 22.6% per year, measured on monthly returns. The largest decline from a peak was −49.2%, with the low in 07/2026.

How does DLB compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, DLB returned +3.0% at 22.6%. The correlation of monthly returns was 0.63; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Dolby Laboratories, Inc. (DLB): Return and risk